You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pharmacogenomics

Showing 1 - 25 of 537
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 2 Diabetes Trial in Lancaster (Exenatide Injection, Saline injection)

Terminated
  • Type 2 Diabetes
  • Exenatide Injection
  • Saline injection
  • Lancaster, Pennsylvania
    Amish Research Clinic
Mar 6, 2023

Pharmacogenomics, Depression Trial (Genomic analysis of antidepressants)

Not yet recruiting
  • Pharmacogenomics
  • Depression
  • Genomic analysis of antidepressants
  • (no location specified)
Dec 29, 2022

Tumors, Bone Marrow Transplantation Trial in Parkville (Release of Extended Pharmacogenomics Report at Week 1, Release of

Not yet recruiting
  • Neoplasms
  • Bone Marrow Transplantation
  • Release of Extended Pharmacogenomics Report at Week 1
  • Release of Extended Pharmacogenomics Report at Week 13
  • Parkville, Victoria, Australia
    The Royal Children's Hospital
Dec 19, 2022

Depressive Disorder, Pharmacogenomic Drug Interaction Trial in Hangzhou (pharmacogenomic testing)

Completed
  • Depressive Disorder
  • Pharmacogenomic Drug Interaction
  • pharmacogenomic testing
  • Hangzhou, Zhejiang, China
    Second Affiliated Hospital, School of Medicine, Zhejiang Univers
Jul 17, 2023

Implementation of Pre-emptive Pharmacogenomics Testing in

Not yet recruiting
  • Pre-emptive Pharmacogenomics
  • Pharmacogenomics Testing
  • Singapore, Singapore
    Raffles Hospital
Aug 14, 2022

High-Dose Methotrexate Clearance in Diffuse Large B-Cell

Recruiting
  • Central Nervous System Lymphoma
  • Diffuse Large B-Cell Lymphoma
  • Non-Interventional Study
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 8, 2023

Pharmacogenomics of Asparaginase Induced Hepatotoxicity

Suspended
  • Acute Lymphoblastic Leukemia
  • Biospecimen Collection
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Nov 18, 2022

Pharmacogenomics of Contraception: Genetic Variants and

Completed
  • Contraception
  • Blood draw
  • Aurora, Colorado
    University of Colorado Denver
Aug 12, 2022

Palliative Medicine Trial in Phoenix (Pharmacogenomics testing, Pharmacist review)

Terminated
  • Palliative Medicine
  • Pharmacogenomics testing
  • Pharmacist review
  • Phoenix, Arizona
    Mayo Clinic
May 3, 2022

Alcohol Use Disorder Trial in Center City, Rochester (Acamprosate, Placebo)

Recruiting
  • Alcohol Use Disorder
  • Center City, Minnesota
  • +2 more
Sep 19, 2022

Oral Surgeries Trial in Augusta (Local anesthetics, IV sedation drugs and analgesics.)

Enrolling by invitation
  • Oral Surgeries
  • Local anesthetics, IV sedation drugs and analgesics.
  • Augusta, Georgia
    Augusta University-Dental College of Georgia
Jul 19, 2022

Pharmacogenetics, Depressive Disorder, Major, Medication Therapy Management Trial in Tuscaloosa (Pharmacogenomic Screening)

Withdrawn
  • Pharmacogenetics
  • +2 more
  • Pharmacogenomic Screening
  • Tuscaloosa, Alabama
    Tuscaloosa VAMC
Aug 8, 2022

Pediatric Surgical Patient Trial in Boston (oral oxycodone)

Recruiting
  • Pediatric Surgical Patient
  • oral oxycodone
  • Boston, Massachusetts
    Boston Children Hospital
Jun 6, 2022

Chronic Pain Trial in Baltimore (Pharmacogenetic Testing, Pharmacist Consultation Note, Delayed pharmacogenetic testing)

Recruiting
  • Chronic Pain
  • Pharmacogenetic Testing
  • +2 more
  • Baltimore, Maryland
    MedStar Good Samaritan Hospital
Mar 1, 2022

NSCLC Trial in Rockville (Crizotinib - Usual, Crizotinib - Study)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Crizotinib - Usual
  • Crizotinib - Study
  • Rockville, Maryland
    Medicine Invention Design, Inc. - IORG0007849
Oct 5, 2023

Gastrointestinal Diseases Trial in Rochester (Pharmacogenomics (PGx) genetic testing)

Completed
  • Gastrointestinal Diseases
  • Pharmacogenomics (PGx) genetic testing
  • Rochester, Minnesota
    Mayo Clinic Rochester
Oct 5, 2022

Cardiovascular Drugs Adverse Reaction

Recruiting
  • Pharmacogenetics
  • +2 more
  • Oral Anticoagulant, Direct-Acting
  • Zagreb, Croatia
    UHC Zagreb
Mar 23, 2022

MDD Trial in Boston (GeneSight Psychotropic test, Canadian Network for Mood and Anxiety Treatment (CANMAT) Best Practice

Completed
  • Major Depressive Disorder
  • GeneSight Psychotropic test
  • Canadian Network for Mood and Anxiety Treatment (CANMAT) Best Practice Guidelines
  • Boston, Massachusetts
    Massachusetts General Hospital
Apr 5, 2022

NSCLC Trial in Rockville (Crizotinib - Usual, Crizotinib - Study)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Crizotinib - Usual
  • Crizotinib - Study
  • Rockville, Maryland
    Medicine Invention Design, Inc. - IORG0007849
Aug 15, 2023

Breast Cancer Trial in Washington, Baltimore, Boston (Ribociclib)

Recruiting
  • Breast Cancer
  • Washington, District of Columbia
  • +3 more
Feb 15, 2022

Depression Trial in New York (Genomind®Professional PGx Express TM)

Withdrawn
  • Depression
  • Genomind®Professional PGx Express TM
  • New York, New York
    Weill Cornell Medicine
Oct 29, 2021

Cardiovascular Diseases, Acute Coronary Syndrome Trial in Newark, Baltimore, Danville (clopidogrel, prasugrel)

Terminated
Has Results
  • Cardiovascular Diseases
  • Acute Coronary Syndrome
  • Newark, Delaware
  • +4 more
Mar 7, 2022

Major Depressive Disorder:Observational Prospective RAndomized,

Recruiting
  • Major Depressive Disorder
  • Pharmacogenomics test (PGx)
  • Brescia, BS, Italy
    Department of Mental Health and Addiction
Sep 12, 2022

Liquid Oxycodone Trial in Boston (liquid oxycodone)

Recruiting
  • Liquid Oxycodone
  • liquid oxycodone
  • Boston, Massachusetts
    Boston Children Hospital
Aug 21, 2022

Precision Medicine Platform for Novel Oral Anticoagulants

Recruiting
  • Anticoagulant Adverse Reaction
  • Pharmacogenomics
  • Kaohsiung, Taiwan
    Kaohsiung Medical University Hospital
Aug 30, 2021